These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 29174675
1. Designing an immunocyte-targeting delivery system by use of beta-glucan. Miyamoto N, Mochizuki S, Sakurai K. Vaccine; 2018 Jan 02; 36(1):186-189. PubMed ID: 29174675 [Abstract] [Full Text] [Related]
2. Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs. Mochizuki S, Morishita H, Kobiyama K, Aoshi T, Ishii KJ, Sakurai K. J Control Release; 2015 Dec 28; 220(Pt A):495-502. PubMed ID: 26562685 [Abstract] [Full Text] [Related]
3. Oligonucleotide delivery to antigen presenting cells by using schizophyllan. Mochizuki S, Miyamoto N, Sakurai K. Drug Metab Pharmacokinet; 2022 Feb 28; 42():100434. PubMed ID: 34896749 [Abstract] [Full Text] [Related]
4. Adjuvant Activity Enhanced by Cross-Linked CpG-Oligonucleotides in β-Glucan Nanogel and Its Antitumor Effect. Miyamoto N, Mochizuki S, Fujii S, Yoshida K, Sakurai K. Bioconjug Chem; 2017 Feb 15; 28(2):565-573. PubMed ID: 27951636 [Abstract] [Full Text] [Related]
5. Dectin-1 targeting delivery of TNF-α antisense ODNs complexed with β-1,3-glucan protects mice from LPS-induced hepatitis. Mochizuki S, Sakurai K. J Control Release; 2011 Apr 30; 151(2):155-61. PubMed ID: 21281680 [Abstract] [Full Text] [Related]
6. A novel β-glucan-oligonucleotide complex selectively delivers siRNA to APCs via Dectin-1. Uno A, Arima K, Shimazaki M, Ushida M, Amano K, Namikawa R, Sakurai K. J Control Release; 2021 Oct 10; 338():792-803. PubMed ID: 34530053 [Abstract] [Full Text] [Related]
7. Binding assay between murine Dectin-1 and β-glucan/DNA complex with quartz-crystal microbalance. Mochizuki S, Morishita H, Adachi Y, Yamaguchi Y, Sakurai K. Carbohydr Res; 2014 Jun 04; 391():1-8. PubMed ID: 24732035 [Abstract] [Full Text] [Related]
8. Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist. Kobiyama K, Aoshi T, Narita H, Kuroda E, Hayashi M, Tetsutani K, Koyama S, Mochizuki S, Sakurai K, Katakai Y, Yasutomi Y, Saijo S, Iwakura Y, Akira S, Coban C, Ishii KJ. Proc Natl Acad Sci U S A; 2014 Feb 25; 111(8):3086-91. PubMed ID: 24516163 [Abstract] [Full Text] [Related]
9. Complex Consisting of β-Glucan and Antigenic Peptides with Cleavage Site for Glutathione and Aminopeptidases Induces Potent Cytotoxic T Lymphocytes. Mochizuki S, Morishita H, Sakurai K. Bioconjug Chem; 2017 Sep 20; 28(9):2246-2253. PubMed ID: 28738674 [Abstract] [Full Text] [Related]
10. Synthesis and in vitro characterization of antigen-conjugated polysaccharide as a CpG DNA carrier. Shimada N, Ishii KJ, Takeda Y, Coban C, Torii Y, Shinkai S, Akira S, Sakurai K. Bioconjug Chem; 2006 Sep 20; 17(5):1136-40. PubMed ID: 16984120 [Abstract] [Full Text] [Related]
11. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses. Jin JW, Tang SQ, Rong MZ, Zhang MQ. Acta Biomater; 2018 Sep 15; 78():211-223. PubMed ID: 30098441 [Abstract] [Full Text] [Related]
12. Naphthalene-hydrophobized β-1,3-glucan nanogel for doxorubicin delivery to immunocytes. Maeda K, Mochizuki S, Sanada Y, Sakurai K. Bioorg Med Chem Lett; 2014 Apr 15; 24(8):1880-3. PubMed ID: 24684841 [Abstract] [Full Text] [Related]
13. Enhanced Therapeutic Efficacy of Immunostimulatory CpG-ODN by Silencing SOCS-1 with Polysaccharide/miR-155 Complexes. Sumiya K, Izumi H, Sakurai K. ACS Appl Bio Mater; 2023 Feb 20; 6(2):774-783. PubMed ID: 36632777 [Abstract] [Full Text] [Related]
14. Induction of humoral and cellular immune response to hepatitis B virus (HBV) vaccine can be upregulated by CpG oligonucleotides complexed with Dectin-1 ligand. Ito H, Ando T, Nakamura M, Ishida H, Kanbe A, Kobiyama K, Yamamoto T, Ishii KJ, Hara A, Seishima M, Ishikawa T. J Viral Hepat; 2017 Feb 20; 24(2):155-162. PubMed ID: 27807909 [Abstract] [Full Text] [Related]
15. Repolarization of glioblastoma macrophage cells using non-agonistic Dectin-1 ligand encapsulating TLR-9 agonist: plausible role in regenerative medicine against brain tumor. Tiwari RK, Singh S, Gupta CL, Pandey P, Singh VK, Sayyed U, Shekh R, Bajpai P. Int J Neurosci; 2021 Jun 20; 131(6):591-598. PubMed ID: 32250189 [Abstract] [Full Text] [Related]
16. Yeast β-D-glucan functionalized graphene oxide for macrophage-targeted delivery of CpG oligodeoxynucleotides and synergistically enhanced antitumor immunity. Cheng T, Yan T, Wu J, Wang Q, Zhang H. Int J Biol Macromol; 2023 Apr 15; 234():123432. PubMed ID: 36716835 [Abstract] [Full Text] [Related]
17. A new therapeutic approach using a schizophyllan-based drug delivery system for inflammatory bowel disease. Takedatsu H, Mitsuyama K, Mochizuki S, Kobayashi T, Sakurai K, Takeda H, Fujiyama Y, Koyama Y, Nishihira J, Sata M. Mol Ther; 2012 Jun 15; 20(6):1234-41. PubMed ID: 22334022 [Abstract] [Full Text] [Related]
18. Innovative strategies for co-delivering antigens and CpG oligonucleotides. Krishnamachari Y, Salem AK. Adv Drug Deliv Rev; 2009 Mar 28; 61(3):205-17. PubMed ID: 19272328 [Abstract] [Full Text] [Related]
19. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides. Takahashi H, Misato K, Aoshi T, Yamamoto Y, Kubota Y, Wu X, Kuroda E, Ishii KJ, Yamamoto H, Yoshioka Y. Front Immunol; 2018 Mar 28; 9():783. PubMed ID: 29720976 [Abstract] [Full Text] [Related]
20. Induction of potent cell growth inhibition by schizophyllan/K-ras antisense complex in combination with gemcitabine. Sasaki S, Izumi H, Morimoto Y, Sakurai K, Mochizuki S. Bioorg Med Chem; 2020 Sep 15; 28(18):115668. PubMed ID: 32828430 [Abstract] [Full Text] [Related] Page: [Next] [New Search]